Juxtacrine signaling inhibits antitumor immunity by upregulating PD-L1 expression.

about

Juxtacrine signaling inhibits antitumor immunity by upregulating PD-L1 expression.

Item

http://www.wikidata.org/entity/Q54107814

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Juxtacrine signaling inhibits antitumor immunity by upregulating PD-L1 expression.

@en

Juxtacrine signaling inhibits antitumor immunity by upregulating PD-L1 expression.

@nl

type

Item

label

Juxtacrine signaling inhibits antitumor immunity by upregulating PD-L1 expression.

@en

Juxtacrine signaling inhibits antitumor immunity by upregulating PD-L1 expression.

@nl

prefLabel

Juxtacrine signaling inhibits antitumor immunity by upregulating PD-L1 expression.

@en

Juxtacrine signaling inhibits antitumor immunity by upregulating PD-L1 expression.

@nl

P1476

Juxtacrine signaling inhibits antitumor immunity by upregulating PD-L1 expression.

@en

P2093

Guoxin Ren

http://www.w3.org/2001/XMLSchema#string

Heng-Huan Lee

http://www.w3.org/2001/XMLSchema#string

Jennifer L Hsu

http://www.w3.org/2001/XMLSchema#string

Jong-Ho Cha

http://www.w3.org/2001/XMLSchema#string

Mien-Chie Hung

http://www.w3.org/2001/XMLSchema#string

Weiya Xia

http://www.w3.org/2001/XMLSchema#string

Wen-Hao Yang

http://www.w3.org/2001/XMLSchema#string

Ying-Nai Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Predictive factors of activity of anti-programmed death-1/programmed death ligand-1 drugs: immunohistochemistry analysis

Immune checkpoint blockade: a common denominator approach to cancer therapy

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II molecules.

Eph receptors and ephrins in cancer: bidirectional signalling and beyond.

The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity

A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages.

EphA2 activation promotes the endothelial cell inflammatory response: a potential role in atherosclerosis

Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future.

P304

3761-3768

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-18-0040

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Li-Chuan Chan

P577

2018-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29789418

http://www.w3.org/2001/XMLSchema#string

P932

6050079

http://www.w3.org/2001/XMLSchema#string